Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 1270 | 11.5 |
09:54 ET | 300 | 11.5492 |
09:56 ET | 200 | 11.475 |
10:03 ET | 1600 | 11.455 |
10:10 ET | 3000 | 11.35 |
10:12 ET | 100 | 11.13 |
10:15 ET | 1628 | 11.35 |
10:17 ET | 300 | 11.4209 |
10:19 ET | 400 | 11.4586 |
10:30 ET | 500 | 11.3593 |
10:32 ET | 200 | 11.41 |
10:35 ET | 400 | 11.47 |
10:37 ET | 1700 | 11.51 |
10:39 ET | 200 | 11.5818 |
10:42 ET | 200 | 11.602 |
10:44 ET | 600 | 11.4542 |
10:51 ET | 1859 | 11.4 |
10:55 ET | 100 | 11.58 |
11:02 ET | 100 | 11.4705 |
11:08 ET | 100 | 11.51 |
11:09 ET | 100 | 11.57 |
11:20 ET | 300 | 11.65 |
11:26 ET | 100 | 11.5601 |
11:27 ET | 1100 | 11.67 |
11:47 ET | 100 | 11.69 |
11:49 ET | 765 | 11.8 |
11:54 ET | 200 | 11.8085 |
11:56 ET | 300 | 11.78 |
11:58 ET | 1900 | 11.78 |
12:00 ET | 700 | 11.7765 |
12:02 ET | 200 | 11.7658 |
12:03 ET | 300 | 11.77 |
12:05 ET | 200 | 11.68 |
12:07 ET | 100 | 11.7659 |
12:21 ET | 980 | 11.75 |
12:23 ET | 100 | 11.76 |
12:32 ET | 200 | 11.7883 |
12:34 ET | 108 | 11.75 |
12:36 ET | 4800 | 11.79 |
12:38 ET | 100 | 11.72 |
12:45 ET | 200 | 11.7976 |
12:50 ET | 300 | 11.8055 |
12:56 ET | 900 | 11.74 |
01:03 ET | 100 | 11.74 |
01:08 ET | 100 | 11.76 |
01:12 ET | 6504 | 11.76 |
01:30 ET | 100 | 11.88 |
01:33 ET | 200 | 11.95 |
01:42 ET | 2381 | 11.95 |
01:44 ET | 167 | 11.9932 |
01:46 ET | 200 | 12.015 |
01:50 ET | 4992 | 12.105 |
01:51 ET | 2224 | 12.105 |
01:53 ET | 400 | 12.105 |
01:57 ET | 6498 | 11.97 |
02:00 ET | 750 | 11.92 |
02:02 ET | 7216 | 11.925 |
02:04 ET | 200 | 11.91 |
02:06 ET | 100 | 11.85 |
02:08 ET | 800 | 11.78 |
02:11 ET | 800 | 11.84 |
02:13 ET | 329 | 11.85 |
02:20 ET | 600 | 11.845 |
02:24 ET | 6605 | 11.785 |
02:26 ET | 1895 | 11.735 |
02:29 ET | 354 | 11.7 |
02:31 ET | 300 | 11.755 |
02:33 ET | 300 | 11.785 |
02:36 ET | 100 | 11.75 |
02:38 ET | 800 | 11.73 |
02:42 ET | 200 | 11.78 |
02:44 ET | 400 | 11.74 |
02:45 ET | 100 | 11.74 |
02:47 ET | 6400 | 11.73 |
02:49 ET | 100 | 11.7 |
02:51 ET | 500 | 11.725 |
02:54 ET | 300 | 11.7 |
02:56 ET | 300 | 11.7 |
02:58 ET | 320 | 11.7 |
03:00 ET | 100 | 11.73 |
03:02 ET | 600 | 11.7 |
03:03 ET | 500 | 11.71 |
03:07 ET | 498 | 11.73 |
03:09 ET | 500 | 11.75 |
03:14 ET | 400 | 11.72 |
03:16 ET | 400 | 11.72 |
03:20 ET | 700 | 11.79 |
03:21 ET | 500 | 11.79 |
03:23 ET | 1200 | 11.77 |
03:25 ET | 661 | 11.74 |
03:27 ET | 400 | 11.73 |
03:30 ET | 500 | 11.765 |
03:32 ET | 430 | 11.775 |
03:34 ET | 400 | 11.75 |
03:36 ET | 600 | 11.8 |
03:38 ET | 400 | 11.76 |
03:39 ET | 200 | 11.75 |
03:41 ET | 500 | 11.74 |
03:43 ET | 400 | 11.74 |
03:45 ET | 400 | 11.74 |
03:48 ET | 1874 | 11.78 |
03:50 ET | 600 | 11.76 |
03:52 ET | 1502 | 11.85 |
03:54 ET | 2610 | 11.91 |
03:56 ET | 7025 | 11.97 |
03:57 ET | 4112 | 12.03 |
03:59 ET | 22352 | 12.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 665.5M | -14.8x | --- |
Nano-X Imaging Ltd | 395.3M | -6.4x | --- |
Atlantic International Corp | 268.0M | -0.4x | --- |
Orchestra Biomed Holdings Inc | 289.2M | -5.5x | --- |
Cibus Inc | 205.7M | -0.4x | --- |
MaxCyte Inc | 385.8M | -10.4x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $665.5M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-0.82 |
Book Value | $0.80 |
P/E Ratio | -14.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.